RASSF2 associates with and stabilizes the proapoptotic kinase MST2

Oncogene

Volumn 28, Issue 33, 2009, Pages 2988-2998

  Cooper, W N ^a   Hesson, L B ^a,b   Matallanas, D ^c   Dallol, A ^a   Von Kriegsheim, A ^c   Ward, R ^b   Kolch, W ^c,d   Latif, F ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Epigenetics; MST; MST2; Proteomics; RASSF2

Indexed keywords

BINDING PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; PROTEIN MST1; PROTEIN MST2; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN HEK293; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOPLASM; GENE LOCATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; EPIGENESIS, GENETIC; HEPATOCYTE GROWTH FACTOR; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 69249217720     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.152     Document Type: Article

References (39)

1. Agathanggelou A, Cooper WN, Latif F. (2005). Role of the rasassociation domain family 1 tumor suppressor gene in human cancers. Cancer Res 65: 3497-3508.
2. Callus BA, Verhagen AM, Vaux DL. (2006). Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J 273: 4264-4276.
3. Cheung WL, Ajiro K, Samejima K, Kloc M, Cheung P, Mizzen CA et al. (2003). Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113: 507-517.
4. Cooper WN, Dickinson RE, Dallol A, Grigorieva EV, Pavlova TV, Hesson LB et al. (2008). Epigenetic regulation of the ras effector/ tumour suppressor RASSF2 in breast and lung cancer. Oncogene 27: 1805-1811.
5. Creasy CL, Ambrose DM, Chernoff J. (1996). The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain. J Biol Chem 271: 21049-21053.
6. Dallol A, Agathanggelou A, Fenton SL, Ahmed-Choudhury J, Hesson L, Vos MD et al. (2004). RASSFIA interacts with microtubuleassociated proteins and modulates microtubule dynamics. Cancer Res 64: 4112-4116.
7. Deng Y, Pang A, Wang JH. (2003). Regulation of mammalian STE20- like kinase 2 (MST2) by protein phosphorylation/dephosphorylation and proteolysis. J Biol Chem 278: 11760-11767.
8. Durocher Y, Perret S, Kamen A. (2002). High-level and highthroughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30: E9.
9. Endoh M, Tamura G, Honda T, Homma N, Terashima M, Nishizuka S et al. (2005). RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer. Br J Cancer 93: 1395-1399.
10. Fenton SL, Dallol A, Agathanggelou A, Hesson L, Ahmed- Choudhury J, Baksh S et al. (2004). Identification of the E1Aregulated transcription factor p120(E4F) as an interacting partner of the RASSF1A candidate tumor suppressor gene. Cancer Res 64: 102-107.
11. Glantschnig H, Rodan GA, Reszka AA. (2002). Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. J Biol Chem 277: 42987-42996.
12. Graves JD, Draves KE, Gotoh Y, Krebs EG, Clark EA. (2001). Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/ Fas-induced apoptosis. J Biol Chem 276: 14909-14915.
13. Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DKM, Wright M et al. (1998). Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J 17: 2224-2234.
14. Guo C, Tommasi S, Liu L, Yee JK, Dammann R, Pfeifer GP. (2007). RASSF1A is part of a complex similar to the Drosophila Hippo/ Salvador/Lats tumor-suppressor network. Curr Biol 17: 700-705.
15. Hesson LB, Wilson R, Morton D, Adams C, Walker M, Maher ER et al. (2005). CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Oncogene 24: 3987-3994.
16. Hu Y, Liu Z, Yang SJ, Ye K. (2007). Acinus-provoked protein kinase C delta isoform activation is essential for apoptotic chromatin condensation. Cell Death Differ 14: 2035-2046.
17. Hwang E, Ryu KS, Paakkonen K, Guntert P, Cheong HK, Lim DS et al. (2007). Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci USA 104: 9236-9241.
18. Imai T, Toyota M, Suzuki H, Akino K, Ogi K, Sogabe Y et al. (2008). Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma. Cancer Sci 99: 958-966.
19. Kaira K, Sunaga N, Tomizawa Y, Yanagitani N, Ishizuka T, Saito R et al. (2007). Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers. Int J Oncol 31: 169-173.
20. Kakeya H, Onose R, Osada H. (1998). Caspase-mediated activation of a 36-kDa myelin basic protein kinase during anticancer drug-induced apoptosis. Cancer Res 58: 4888-4894.
21. Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang XF et al. (2002). Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 12: 253-265.
22. Kriegsheim A, Preisinger C, Kolch W. (2008). Mapping of signaling pathways by functional interaction proteomics. Methods Mol Biol 484: 177-192.
23. Kumari G, Singhal PK, Rao MR, Mahalingam S. (2007). Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals. J Mol Biol 367: 1294-1311.
24. Kuznetsov S, Khokhlatchev AV. (2008). The growth and tumor suppressors NORE1A and RASSF1A are targets for calpainmediated proteolysis. PLoS ONE 3: e3997.
25. Lee KK, Ohyama T, Yajima N, Tsubuki S, Yonehara S. (2001). MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem 276: 19276-19285.
26. Lee KK, Yonehara S. (2002). Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST). J Biol Chem 277: 12351-12358.
27. Liao X, Siu MK, Chan KY, Wong ES, Ngan HY, Chan QK et al. (2008). Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis. Int J Cancer 123: 296-302.
28. Lin Y, Khokhlatchev A, Figeys D, Avruch J. (2002). Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis. J Biol Chem 277: 47991-48001.
29. Maruyama R, Akino K, Toyota M, Suzuki H, Imai T, Ohe-Toyota M et al. (2008). Cytoplasmic RASSF2A is a pro-apoptotic mediator whose expression is epigenetically silenced in gastric cancer. Carcinogenesis.
30. O'Neill E, Rushworth L, Baccarini M, Kolch W. (2004). Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 306: 2267-2270.
31. Oh HJ, Lee KK, Song SJ, Jin MS, Song MS, Lee JH et al. (2006). Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res 66: 2562-2569.
32. Praskova M, Khoklatchev A, Ortiz-Vega S, Avruch J. (2004). Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem J 381: 453-462.
33. Rabizadeh S, Xavier RJ, Ishiguro K, Bernabeortiz J, Lopez-IlasacaM, Khokhlatchev A et al. (2004). The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1Ainduced cell death. J Biol Chem 279: 29247-29254.
34. Reszka AA, Halasy-Nagy JM, Masarachia PJ, Rodan GA. (1999). Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosispromoting kinase. J Biol Chem 274: 34967-34973.
35. Scheel H, Hofmann K. (2003). A novel interaction motif, SARAH, connects three classes of tumor suppressor. Curr Biol 13: R899-900.
36. Ura S, Masuyama N, Graves JD, Gotoh Y. (2001). Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proc Natl Acad Sci USA 98: 10148-10153.
37. Ura S, Nishina H, Gotoh Y, Katada T. (2007). Activation of the c-Jun N-terminal kinase pathway by MST1 is essential and sufficient for the induction of chromatin condensation during apoptosis. Mol Cell Biol 27: 5514-5522.
38. von Kriegsheim A, Pitt A, Grindlay GJ, Kolch W, Dhillon AS. (2006). Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5. Nat Cell Biol 8: 1011-1016.
39. Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ. (2003). RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem 278: 28045-28051.